154 related articles for article (PubMed ID: 17058904)
1. [Sunitinib for gastrointestinal stromal cell tumors and advanced renal cell carcinoma].
Vollmer H
Med Monatsschr Pharm; 2006 Oct; 29(10):386-7. PubMed ID: 17058904
[No Abstract] [Full Text] [Related]
2. [News on ASCO 2007. Sunitinib in the treatment of metastatic renal carcinoma and gastrointestinal stromal tumors].
Mansueto G; Longo F
Tumori; 2007; 93(5):Suppl 1-16. PubMed ID: 18038894
[No Abstract] [Full Text] [Related]
3. Sunitinib maleate.
Atkins M; Jones CA; Kirkpatrick P
Nat Rev Drug Discov; 2006 Apr; 5(4):279-80. PubMed ID: 16628834
[No Abstract] [Full Text] [Related]
4. Approval summary: sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinoma.
Goodman VL; Rock EP; Dagher R; Ramchandani RP; Abraham S; Gobburu JV; Booth BP; Verbois SL; Morse DE; Liang CY; Chidambaram N; Jiang JX; Tang S; Mahjoob K; Justice R; Pazdur R
Clin Cancer Res; 2007 Mar; 13(5):1367-73. PubMed ID: 17332278
[TBL] [Abstract][Full Text] [Related]
5. Cardiotoxicity associated with sunitinib.
Hariharan S; Lowry S
Lancet; 2008 Apr; 371(9620):1244-5; author reply 1245. PubMed ID: 18406854
[No Abstract] [Full Text] [Related]
6. Sunitinib in solid tumors.
Gan HK; Seruga B; Knox JJ
Expert Opin Investig Drugs; 2009 Jun; 18(6):821-34. PubMed ID: 19453268
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine kinase inhibition in renal cell carcinoma and gastrointestinal stromal tumours: case reports.
Schöffski P; Bukowski R; Flodgren P; Ravaud A
Ann Oncol; 2009 May; 20 Suppl 1():i25-i30. PubMed ID: 19430005
[TBL] [Abstract][Full Text] [Related]
8. Food and Drug Administration drug approval summary: Sunitinib malate for the treatment of gastrointestinal stromal tumor and advanced renal cell carcinoma.
Rock EP; Goodman V; Jiang JX; Mahjoob K; Verbois SL; Morse D; Dagher R; Justice R; Pazdur R
Oncologist; 2007 Jan; 12(1):107-13. PubMed ID: 17227905
[TBL] [Abstract][Full Text] [Related]
9. Sunitinib.
Heng DY; Kollmannsberger C
Recent Results Cancer Res; 2010; 184():71-82. PubMed ID: 20072832
[TBL] [Abstract][Full Text] [Related]
10. Sunitinib: new drug. For some gastrointestinal stromal tumours.
Prescrire Int; 2007 Aug; 16(90):138-41. PubMed ID: 17724833
[TBL] [Abstract][Full Text] [Related]
11. Improvement of psoriasis during sunitinib therapy for renal cell carcinoma.
Narayanan S; Callis-Duffin K; Batten J; Agarwal N
Am J Med Sci; 2010 Jun; 339(6):580-1. PubMed ID: 20421784
[TBL] [Abstract][Full Text] [Related]
12. New challenges in kidney cancer therapy: sunitinib.
Izzedine H; Billemont B; Thibault F; Rixe O
Ann Oncol; 2007 Jul; 18 Suppl 9():ix83-6. PubMed ID: 17631600
[No Abstract] [Full Text] [Related]
13. Consolidative renal cell carcinoma metastatectomy for partial response after multitargeted tyrosine kinase inhibitor therapy.
Neill MG; Wei AC; Jewett MA
Urology; 2007 Jul; 70(1):178.e9-11. PubMed ID: 17656238
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacology profile of sunitinib malate (Sutent) Capsules) and clinical findings on this drug].
Tahara M; Shibata A; Yamaguchi S; Hamada Y
Nihon Yakurigaku Zasshi; 2009 Apr; 133(4):215-26. PubMed ID: 19367024
[No Abstract] [Full Text] [Related]
15. Sunitinib: from rational design to clinical efficacy.
Chow LQ; Eckhardt SG
J Clin Oncol; 2007 Mar; 25(7):884-96. PubMed ID: 17327610
[TBL] [Abstract][Full Text] [Related]
16. Sunitinib for imatinib-resistant GIST.
Joensuu H
Lancet; 2006 Oct; 368(9544):1303-4. PubMed ID: 17046443
[No Abstract] [Full Text] [Related]
17. Sunitinib.
Deeks ED; Keating GM
Drugs; 2006; 66(17):2255-66; discussion 2267-8. PubMed ID: 17137406
[TBL] [Abstract][Full Text] [Related]
18. Transient sunitinib resistance in gastrointestinal stromal tumors.
Bracci R; Maccaroni E; Cascinu S
N Engl J Med; 2013 May; 368(21):2042-3. PubMed ID: 23697529
[No Abstract] [Full Text] [Related]
19. Sunitinib-induced hypothyroidism is due to induction of type 3 deiodinase activity and thyroidal capillary regression.
Kappers MH; van Esch JH; Smedts FM; de Krijger RR; Eechoute K; Mathijssen RH; Sleijfer S; Leijten F; Danser AH; van den Meiracker AH; Visser TJ
J Clin Endocrinol Metab; 2011 Oct; 96(10):3087-94. PubMed ID: 21816788
[TBL] [Abstract][Full Text] [Related]
20. [New drugs; sunitinib and sorafenib].
van Bronswijk H; Dubois EA; Osanto S; Cohen AF
Ned Tijdschr Geneeskd; 2007 Dec; 151(52):2888-90. PubMed ID: 18257434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
